Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression

Journal of Pathology

Volumn 222, Issue 3, 2010, Pages 310-319

  Tchernitsa, Oleg ^a   Kasajima, Atsuko ^a   Schäfer, Reinhold ^a   Kuban, Ralf Jürgen ^a   Ungethüm, Ute ^a   Györffy, Balazs ^a,b   Neumann, Ulf ^a   Simon, Eva ^c   Weichert, Wilko ^a   Ebert, Matthias P A ^d   Röcken, Christoph ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF KIEL   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dicer; Drosha; Gastric cancer; Lymph node metastases; MiRNA; Prognosis

Indexed keywords

DICER; MICRORNA; PROTEIN 106 B; PROTEIN 146 A; PROTEIN DROSHA; PROTEIN MIR 103; PROTEIN MIR 145; PROTEIN MIR 148 A; PROTEIN MIR 21; UNCLASSIFIED DRUG; DROSHA PROTEIN, HUMAN; RIBONUCLEASE III; RNA; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA, NEOPLASM; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77957978941     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2759     Document Type: Article

References (31)

1. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003;14(Suppl 2): ii31-ii36.
2. Kobayashi T, Kikuchi S, Lin Y, et al. Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 2004;7:233-239.
3. Cowland JB, Hother C, Gronbaek K. MicroRNAs and cancer. APMIS 2007;115:1090-1106.
4. Fabbri M, Croce CM, Calin GA. MicroRNAs. Cancer J 2008;14:1-6.
5. Wu M, Jolicoeur N, Li Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008;29:1710-1716.
6. Landi D, Gemignani F, Barale R, et al. A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol 2008;27:35-43.
7. Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008;359:2641-2650.
8. Faggad A, Budczies J, Tchernitsa O, et al. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol 2010;220:382-391.
9. Lauren T. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
10. Ingold B, Simon E, Ungethüm U, et al. Vascular CXCR4 expression-a novel antiangiogenic target in gastric cancer? PLoS One 2010;5: e10087.
11. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nature Biotechnol 2008;26:462-469.
12. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-2261.
13. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-146.
14. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-419.
15. Siomi H, Siomi MC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 2010;38:323-332.
16. Grelier G, Voirin N, Ay AS, et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009;101:673-683.
17. Chan SH, Wu CW, Li AF, et al. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008;28:907-911.
18. Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009;24:652-657.
19. Zhang Z, Li Z, Gao C, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008;88:1358-1366.
20. Kim YK, Yu J, Han TS, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009;37:1672-1681.
21. Liu T, Tang H, Lang Y, et al. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273:233-242.
22. Takagi T, Iio A, Nakagawa Y, et al. Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 2009;77:12-21.
23. Ando T, Yoshida T, Enomoto S, et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009;124:2367-2374.
24. Kim DN, Chae HS, Oh ST, et al. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 2007;81:1033-1036.
25. Zhao XY, Chen L, Li YH, et al. Plexin A1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation. World J Gastroenterol 2007;13:6558-6561.
26. Gupta S, Kass GE, Szegezdi E, et al. The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med 2009;13:1004-1033.
27. Craig RW. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 2002;16:444-454.
28. Tsang HT, Edwards TL, Wang X, et al. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 2009;18:3805-3821.
29. Schmidt A, Durgan J, Magalhaes A, et al. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J 2007;26:1624-1636.
30. Takeda M, Arao T, Yokote H, et al. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor. Clin Cancer Res 2007;13:3051-3057.
31. Sasaki H, Miura K, Horii A, et al. Orthotopic implantation mouse model and cDNA microarray analysis indicates several genes potentially involved in lymph node metastasis of colorectal cancer. Cancer Sci 2008;99:711-719.